Pure red cell aplasia in patients with refractory anaemia treated with two different recombinant erythropoietins [3]

British Journal of Haematology

Volumn 124, Issue 6, 2004, Pages 842-

  Quint, Laurent ^a   Casadevall, Nicole ^b   Giraudier, Stephane ^c  

^a INSTITUT MUTUALISTE MONTSOURIS   (France)

^b HÔTEL DIEU   (France)

^c Department of Haematology ^*  (France)

Author keywords

Anaemia; Anti erythropoietin antibodies; Epoetin; Pure red cell aplasia

Indexed keywords

CYCLOSPORIN A; MELPHALAN; RECOMBINANT ERYTHROPOIETIN;

AGED; BLOOD TRANSFUSION; CASE REPORT; DRUG WITHDRAWAL; ERYTHROID PRECURSOR CELL; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY FUNCTION; LABORATORY TEST; LETTER; MALE; PRIORITY JOURNAL; PURE RED CELL ANEMIA; REFRACTORY ANEMIA; RETICULOCYTE COUNT;

AGED; ANEMIA, REFRACTORY; ERYTHROPOIETIN, RECOMBINANT; HUMANS; MALE; RED-CELL APLASIA, PURE;

EID: 1642331345     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.04861.x     Document Type: Letter

References (2)

1. Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J.J., Dupont, P.M., Michaud, P., Papo, T., Ugo, V., Teyssandier, I., Varet, B. & Mayeux, P. (2002) Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. New England Journal of Medicine, 346, 469-475.
2. Rizzo, J.D., Lichtin, A.E., Woolf, S.H., Seidenfeld, J., Bennett, C.L., Cella, D., Djulbegovic, B., Goode, M.J., Jakubowski; A.A., Lee, S.J., Miller, C.B., Rarick, M.U., Regan, D.H., Browman, G.P. & Gordon, M.S. (2002) Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood, 100, 2303-2320.